Annual CFF
-$4.34 M
+$665.10 K+13.29%
December 31, 2023
Summary
- As of February 7, 2025, KTTA annual cash flow from financing activities is -$4.34 million, with the most recent change of +$665.10 thousand (+13.29%) on December 31, 2023.
- KTTA annual CFF is now -107.76% below its all-time high of $55.93 million, reached on December 31, 2021.
Performance
KTTA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$4.54 M
+$4.54 M+100.00%
September 30, 2024
Summary
- As of February 7, 2025, KTTA quarterly cash flow from financing activities is $4.54 million, with the most recent change of +$4.54 million (+100.00%) on September 30, 2024.
- Over the past year, KTTA quarterly CFF has increased by +$4.54 million (+100.00%).
- KTTA quarterly CFF is now -86.71% below its all-time high of $34.17 million, reached on December 31, 2021.
Performance
KTTA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$3.93 M
+$8.40 M+187.90%
September 30, 2024
Summary
- As of February 7, 2025, KTTA TTM cash flow from financing activities is $3.93 million, with the most recent change of +$8.40 million (+187.90%) on September 30, 2024.
- Over the past year, KTTA TTM CFF has increased by +$8.40 million (+187.90%).
- KTTA TTM CFF is now -92.97% below its all-time high of $55.93 million, reached on December 31, 2021.
Performance
KTTA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KTTA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.3% | +100.0% | +187.9% |
| 3 y3 years | - | +542.2% | -88.1% |
| 5 y5 years | - | +542.2% | -88.1% |
KTTA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -107.8% | +13.3% | -86.7% | +214.2% | -93.0% | +151.0% |
| 5 y | 5-year | -107.8% | +13.3% | -86.7% | +214.2% | -93.0% | +151.0% |
| alltime | all time | -107.8% | +13.3% | -86.7% | +214.2% | -93.0% | +151.0% |
Pasithea Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.54 M(>+9900.0%) | $3.93 M(-187.9%) |
| Jun 2024 | - | $0.00(0.0%) | -$4.47 M(-2.8%) |
| Mar 2024 | - | $0.00(-100.0%) | -$4.60 M(+6.1%) |
| Dec 2023 | -$4.34 M(-13.3%) | -$611.30 K(-84.2%) | -$4.34 M(-43.7%) |
| Sep 2023 | - | -$3.86 M(+2850.9%) | -$7.70 M(+58.2%) |
| Jun 2023 | - | -$130.80 K(-149.5%) | -$4.87 M(+2.8%) |
| Mar 2023 | - | $264.10 K(-106.6%) | -$4.74 M(-5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$5.00 M(-108.9%) | -$3.98 M(+287.2%) | -$5.00 M(-115.1%) |
| Sep 2022 | - | -$1.03 M(<-9900.0%) | $33.14 M(-39.4%) |
| Jun 2022 | - | $0.00(0.0%) | $54.72 M(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) | $54.72 M(-2.2%) |
| Dec 2021 | $55.93 M | $34.17 M(+66.2%) | $55.93 M(+157.0%) |
| Sep 2021 | - | $20.55 M(>+9900.0%) | $21.76 M(+1700.3%) |
| Jun 2021 | - | $0.00(-100.0%) | $1.21 M(0.0%) |
| Mar 2021 | - | $1.21 M | $1.21 M |
FAQ
- What is Pasithea Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Pasithea Therapeutics?
- What is Pasithea Therapeutics annual CFF year-on-year change?
- What is Pasithea Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Pasithea Therapeutics?
- What is Pasithea Therapeutics quarterly CFF year-on-year change?
- What is Pasithea Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Pasithea Therapeutics?
- What is Pasithea Therapeutics TTM CFF year-on-year change?
What is Pasithea Therapeutics annual cash flow from financing activities?
The current annual CFF of KTTA is -$4.34 M
What is the all time high annual CFF for Pasithea Therapeutics?
Pasithea Therapeutics all-time high annual cash flow from financing activities is $55.93 M
What is Pasithea Therapeutics annual CFF year-on-year change?
Over the past year, KTTA annual cash flow from financing activities has changed by +$665.10 K (+13.29%)
What is Pasithea Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of KTTA is $4.54 M
What is the all time high quarterly CFF for Pasithea Therapeutics?
Pasithea Therapeutics all-time high quarterly cash flow from financing activities is $34.17 M
What is Pasithea Therapeutics quarterly CFF year-on-year change?
Over the past year, KTTA quarterly cash flow from financing activities has changed by +$4.54 M (+100.00%)
What is Pasithea Therapeutics TTM cash flow from financing activities?
The current TTM CFF of KTTA is $3.93 M
What is the all time high TTM CFF for Pasithea Therapeutics?
Pasithea Therapeutics all-time high TTM cash flow from financing activities is $55.93 M
What is Pasithea Therapeutics TTM CFF year-on-year change?
Over the past year, KTTA TTM cash flow from financing activities has changed by +$8.40 M (+187.90%)